Amplia Therapeutics |
High $0.08 |
Low $0.07 |
Trades 8 |
Turnover $9,058 |
Volume 120,981 |
| 30 June 2023 at 2:59pm | ||||
|
Market Cap (16-Nov) $46,198,080 (1,444th) |
Close (30-Jun) $0.076 |
Volume (30-Jun) 120,981 |
Shortsold (9-Nov) 30,144 (0.01%) (594th) |
|
52w High $0.275 |
52w Low $0.076 |
P/E - |
EPS -0.02 |
App 4G - Key to Corporate Governance Disclosures
ATX released this announcement to the ASX on 23 July 2021, 13:58. The announcement is not marked as price sensitive, and is 15 page(s) in length and 404.25kb in size.
You can view all announcements from ATX and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATX was 0.012% short sold according to ASIC data. It was ranked the 606th most shorted stock on the ASX. It is now ranked as the 594th most shorted stock on the ASX with 0.006% of total shares short sold as of the latest reported data (09 November 2026).
| Other Recent Announcements from ATX | |
|---|---|
| AMP945 International Nonproprietary Name Narmafotinib | 21 June 2023, 8:34 |
| Amplia AGM to be held Thursday 24 August 2023 | 19 June 2023, 17:34 |
| Key to Corporate Governance Disclosures | 31 May 2023, 8:14 |
| App 4G - Key to Corporate Governance Disclosures | 23 July 2021, 13:58 |
| 2021 Corporate Governance Statement | 23 July 2021, 13:42 |
| Annual Report to Shareholders - YE 31 March 2021 | 23 July 2021, 13:40 |
| Notice of Annual General Meeting/Proxy Form | 23 July 2021, 13:39 |
If you were already registered, log in here.